Oracle logo

ASCO 2024 Preview Webinar: Key Trials with High Clinical and Commercial Impact

A webinar hosted by Oracle Life Sciences
Live Webinar
Wednesday,
May 22nd, 2024
11am - 12:15pm ET
image
The annual American Society of Clinical Oncology (ASCO) conference will take place May 31 to June 4, 2024, with a profusion of exciting clinical results to be presented. Join us for a review of some of the results that are expected to have a near-term impact on patient care and the pharmaceutical industry and market-moving events in the financial sector.

A panel of experts will share their perspectives on the impact this data will have on clinical practice and commercial implications for pharma and the financial sector.

*This webinar is intended primarily for biopharmaceutical and medical device companies. Due to the proprietary nature of the content, all registrations are at the discretion of Oracle.

Presenters

speaker

Brad Loncar

Founder, BiotechTV
Close

Brad Loncar

Founder, BiotechTV
Brad is the founder of BiotechTV, a daily source of video-based news and educational content for the biotechnology industry. He previously was the CEO of Loncar Investments and through that was the creator of two Nasdaq-listed biotech-focused exchange-traded funds. He worked earlier in his career in the financial services industry at Franklin Templeton Investments where he was a member of the Management Training Program, and was appointed to serve in a Senior Advisor role at the U.S. Department of the Treasury.
speaker

Deborah Wong MD PhD

Associate Clinical Professor of Medicine, Hematology & Oncology, UCLA Medical Center
Close

Deborah Wong MD PhD

Associate Clinical Professor of Medicine, Hematology & Oncology, UCLA Medical Center
Dr. Wong is a hematologist/oncologist and Assistant Clinical Professor of Medicine at UCLA. Her clinical and research focuses are on novel systemic treatments for patients with advanced solid tumors and on clinical advances for head and neck cancer.
speaker

Jay Grisolano PhD

Principal, Oncology & Specialty Therapeutics, Oracle Life Sciences
Close

Jay Grisolano PhD

Principal, Oncology & Specialty Therapeutics, Oracle Life Sciences
Dr. Grisolano has two decades of strategic consulting experience with a focus on custom engagements in the therapeutic areas of oncology and rare disease. He brings scientific, clinical, and commercial expertise to support the needs of clients.

He leads a team of consultants that partner with clients to provide commercially-oriented insights to complex business questions, ranging from market access drivers/barriers to sales forecasts indicative of commercial potential.
speaker

Kelly Clapp PhD

Engagement Manager, Oncology & Specialty Therapeutics, Oracle Life Sciences
Close

Kelly Clapp PhD

Engagement Manager, Oncology & Specialty Therapeutics, Oracle Life Sciences
Dr. Clapp has over 8 years of consulting experience focused in oncology, leading consulting engagements in the area of clinical development strategy and planning for biotech and pharma clients.

She leads Oracle Life Sciences’ Future Trends & Insights offer, which provides an understanding of development trends and implications across global oncology markets.

Moderator

speaker

Stephanie Hawthorne PhD

General Manager, Oncology & Specialty Therapeutics, Oracle Life Sciences
Dr. Hawthorne has over 20 years of consulting experience focused in oncology, with in-depth knowledge of a wide range of solid and hematologic tumors. Her expertise bridges the gap between clinical understanding and commercial implications for the pharmaceutical and biotech industry.

She currently leads a team responsible for Oracle Life Sciences’ CancerMPact® offer, a comprehensive data source for cancer epidemiology and treatment trends for over 30 tumor types across global markets.